Medicinal products containing unknown active substances at unknown concentration pose a significant risk to patients, as an existing illness may remain untreated and possible adverse reactions cannot be determined
This matters because tirzepatide insomnia affects a meaningful percentage of patients, particularly during the first few weeks of treatment or after dose escalations
Sleep Quality: Are you sleeping better and waking up feeling more refreshed
In the statistical analysis, we applied data alignment by Fragment Align using the Pirouette software to perform PCA
Nevison C, Blaxill M, Zahorodny W
Randomised Controlled Trials Two multicentre, randomised, double-blind and placebo-controlled trials assessed controlled-release afamelanotide implants in European and United States participants